Trial Condition(s):

Bacterial Infections

Ciprofloxacin oral suspension administered for 3 days versus ciprofloxacin oral suspension administered for 5 days in children and juveniles for the treatment of Shigella dysenteriae type one dysentery

Bayer Identifier:

Trial_0570

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

253

Trial Dates

May1996

June2000

Phase

Could I receive a placebo?

Products

Cipro (Ciprofloxacin, BAYQ3939)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Locations

Bacterial Infections

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

No Limit

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information